Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

CYRX

Cryoport, Inc.

Pharmaceutical Preparations · SIC 2834CIK 1124524Held by 1 tracked managerEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
$176.0M
Net Income FY2025
$78.0M
EPS (Basic, as reported)
$1.40
Net Margin FY2025
44.4%
ROE FY2025
15.6%
Total Equity
$503.0M
Shares Out
51M
Business description

Cryoport, Inc. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2011–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 6 → 176 +45.6% CAGR
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue612203479223237233228176
Cost of revenue(4)(6)(9)(17)(42)(126)(133)(134)(129)(93)
Gross profit26101736971049910083
Research & development(1)(1)(2)(4)(9)(17)(16)(18)(18)(17)
Selling, general & administrative———(31)(57)(98)(120)(147)(149)(103)
Selling & marketing(4)(5)(7)(14)——————
General & administrative(6)(7)(10)(17)——————
Total operating expenses(11)(14)(19)(35)(66)(114)(136)(214)(230)(120)
Operating income(9)(8)(9)(18)(30)(18)(32)(115)(131)(37)
Interest expense(1)00(1)(3)(5)(6)(6)(4)(2)
Interest & investment income——————————
Other income (expense), net(4)0(1)(1)(3)(256)(3)16175
Pre-tax income(10)(8)(10)(18)(33)(274)(35)(99)(113)(32)
Income tax expense00000(2)(2)0(1)(2)
Net income(10)(8)(10)(18)(33)(276)(37)(100)(115)78
EPS — basic———($0.55)($1.94)($6.18)($0.93)($2.21)($2.49)$1.40
EPS — diluted———($0.55)($1.94)($6.19)($0.93)($2.21)($2.49)$1.40
Shares outstanding — basic (M)———33394649494950
Shares outstanding — diluted (M)———33394649494950

Showing the latest 10 of 15 fiscal years.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.